Clinical Research

56-Day Clinical Study: How C. asiatica Extracellular Vesicles & Recombinant Growth Factors Restore Hair Density and Reduce Hair Loss

Senye-Zhongyan-Youke Research Team·Biotech Cosmetic Research InstitutionMay 13, 20265 min read
56-Day Clinical Study: How C. asiatica Extracellular Vesicles & Recombinant Growth Factors Restore Hair Density and Reduce Hair Loss

A 56-day double-blind clinical trial by Senye-Zhongyan-Youke confirms that plant-derived C. asiatica EVs combined with rIGF-1 & rFGF-7 growth factors reduce daily hair loss by 63.6% and increase hair density by 23.9%. Science-backed, non-pharmaceutical hair care.

Introduction: A Science-Backed Answer to Hair Loss

Hair loss affects hundreds of millions of people worldwide, impacting confidence and quality of life. Senye-Zhongyan-Youke developed a biotech-driven scalp serum combining Centella asiatica Extracellular Vesicles (C. asiatica EVs) with long-acting Recombinant Growth Factors (rIGF-1 and rFGF-7), validated in a 56-day randomized, double-blind, placebo-controlled clinical trial (ClinicalTrials.gov: NCT06985121).


How This Formula Works

1. C. asiatica EVs — Plant-Derived Nanocarriers

Derived from Centella asiatica (Gotu Kola), these EVs penetrate deeply into the scalp to:

  • Reduce scalp inflammation — a key driver of follicle miniaturization
  • Regulate excess sebum production
  • Activate dermal papilla cells to initiate and sustain hair growth

2. Recombinant Growth Factors: rIGF-1 & rFGF-7

Engineered with Fc-fusion technology for extended biological half-life, these growth factors:

  • Prolong the anagen (growth) phase of the hair cycle
  • Prevent premature follicle entry into the catagen (regression) phase
  • Stimulate hair shaft thickening and structural integrity

Clinical Trial Design

Parameter Details
Duration 56 days
Design Randomized, Double-Blind, Placebo-Controlled
Registration NCT06985121
Institution Senye-Zhongyan-Youke
Test Group Group E — Full Formula

Day 56 Results (Group E — Full Formula)

Scalp Sebum Control: −59%

Restores a balanced scalp microenvironment, reducing conditions that accelerate follicle damage.

Hair Length Growth: +3.5 cm

Statistically significant growth differences observed from Day 14 onward.

Hair Diameter (Thickness): +27.9 μm

Thicker hair shafts mean visibly fuller, more resilient hair with reduced breakage.

Hair Density: +23.9%

Measurable increase in follicular unit count per area — significant improvement in overall volume.

Daily Hair Loss: −63.6%

The standout result: nearly two-thirds fewer hairs shed per day compared to baseline.


Conclusion

The combination of plant-derived EVs and long-acting recombinant growth factors delivers a synergistic, multi-target effect — addressing sebum control, growth stimulation, density, and hair loss simultaneously. A safe, effective, science-backed non-pharmaceutical solution for hair and scalp rejuvenation.


About Senye-Zhongyan-Youke

A biotech-driven cosmetic research institution developing clinically validated, plant-science solutions for scalp and hair health.

Tags:hair loss treatmenthair growth serumCentella asiatica extracellular vesiclesrecombinant growth factorsscalp healthclinical studyrIGF-1rFGF-7hair densityanti-hair lossbiotech cosmeticsSenye-Zhongyan-Youke

Share this article

Senye-Zhongyan-Youke Research Team

Biotech Cosmetic Research Institution

Part of SEYE's expert team with deep expertise in cosmetic formulation, OEM manufacturing, and global regulatory compliance.